Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

13.5%

492 terminated/withdrawn out of 3632 trials

Success Rate

81.1%

-5.4% vs industry average

Late-Stage Pipeline

310 trials in Phase 3/4

Results Transparency

36%

763 of 2117 completed trials have results

Key Signals

584 recruiting763 with results310 terminated182 withdrawn

Enrollment Performance

Analytics

N/A

1396(51.8%)

Phase 2

463(17.2%)

Phase 1

427(15.9%)

Phase 4

202(7.5%)

Phase 3

108(4.0%)

Early Phase 1

98(3.6%)

2694Total

N/A(1396)

Phase 2(463)

Phase 1(427)

Phase 4(202)

+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3632)

Showing 20 of 3632 trials

NCT03418038Phase 2Recruiting

Ascorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic Leukemia

Role: lead

NCT05193981Active Not Recruiting

A Study to Evaluate Homocysteine Metabolism and Endothelial Function in ADPKD

Role: lead

NCT06803589Early Phase 1Recruiting

Growth Hormone for the Treatment of Gastroparesis

Role: lead

NCT06874556Recruiting

A Study of Paramedic HF Management

Role: lead

NCT07401888Not ApplicableRecruiting

A Study Of Milk Consumption In Metabolic Syndrome

Role: lead

NCT06275074Not ApplicableActive Not Recruiting

Dry Needling and Therapeutic Exercise on Sleep in Individuals With Chronic Neck Pain and Sleep Disturbance

Role: lead

NCT07308704Recruiting

A Study Of Deep Learning For Echo Analysis, Tracking, And Evaluation

Role: lead

NCT07349771Phase 2Not Yet Recruiting

Axatilimab Plus Standard of Care Therapy for the Prevention of Graft Versus Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Hematologic Cancer, ABRAXAS Trial

Role: lead

NCT06409026Phase 4Completed

Sotatercept on Central Cardiopulmonary Performance and Peripheral Oxygen Transport During Exercise in Pulmonary Arterial Hypertension

Role: lead

NCT01427179Recruiting

Genetic Investigations in Spontaneous Coronary Artery Dissection (SCAD)

Role: lead

NCT06891534Not ApplicableRecruiting

Circadian Rhythms in Human Adipose

Role: lead

NCT05232851Phase 1Active Not Recruiting

A Vaccine (PDS0101) Alone or in Combination With Pembrolizumab for the Treatment of Locally Advanced Human Papillomavirus-Associated Oropharynx Cancer

Role: lead

NCT04334707Recruiting

Kidney Precision Medicine Project

Role: collaborator

NCT07527130Not Yet Recruiting

C11 ER176 PET in Evaluating Neuroinflammation in Patients With Post-COVID Syndrome

Role: lead

NCT07185880Phase 1Recruiting

A Phase 1/2 Study of the Safety and Tolerability of MT-125 in GBM Patients

Role: collaborator

NCT07527143Not Yet Recruiting

Acceptability of Testing DNA Markers in Vaginal Fluid for the Detection of Endometrial Cancer